MGB Biopharma, a biopharmaceutical company developing a truly novel class of anti-infectives, provides an update on its business performance for 2014. MGB Biopharma is developing a pipeline of novel antimicrobials that puts it at the forefront of addressing the major global problem of antimicrobial resistance.
from The Medical News http://ift.tt/1xTNeVI
from The Medical News http://ift.tt/1xTNeVI
No comments:
Post a Comment